Spartans-Lobos to battle for Sweet 16 spot late on Sunday night
Get ready Spartan fans, Sunday night is your time to hopefully see Michigan State get back to the Sweet 16 for the first time in a couple of years.
The Spartans will battle No. 10 seed New Mexico Lobos in the second round of the NCAA Tournament on Sunday. Michigan State knocked off No. 15 seed Bryant in the first round on Friday night to advance and setup a matchup with the Lobos, who beat No. 7 seed Marquette.
Tip off details and viewing options have been released for the Spartans-Lobos matchup on Sunday. See how when and how you can catch Michigan State hoops on Sunday evening below:
Advertisement
TV Details, Tipoff Information
Who: Michigan State vs. New Mexico
Date: Sunday, March 23
Time: 8:40 p.m. ET
TV Channel: TNT
Michigan State will once again play a late night matchup in the NCAA Tournament, with this one against New Mexico for a trip to the Sweet 16. The Spartans opened the tournament playing in one of the final games of the first round and they’ll do the same on Sunday as the second to last scheduled tip time of the second round.
Advertisement
Can your picks survive March Madness? Join our Survivor Pool to find out
The complete Sunday slate of NCAA Tournament games can be seen in the post below:
Contact/Follow us @The SpartansWire on X (formerly Twitter) and like our page onFacebookto follow ongoing coverage of Michigan State news, notes and opinion. You can also follow Robert Bondy on X @RobertBondy5.
Crystal Romero had battled darkness for over a decade, struggling with post-traumatic stress disorder and depression after a long career in the New Mexico Army National Guard. She was treated with antidepressants but didn’t find solace and healing until she was introduced to psilocybin mushrooms in Jamaica.
The Albuquerque mother of three believes the use of psychedelic drugs — at low doses and in a controlled environment — can do tremendous good for people in New Mexico, a state that long has seen high rates of poverty and addiction. Now she wants others to have access to psilocybin-assisted therapy.
“Working with psilocybin has really allowed me to sit with my grief,” Romero said. “Depression doesn’t have to consume your life. I was able to reconnect with myself, reconnect with kids, reconnect with my community.”
Advertisement
Under new legislation, New Mexico is following the path of Oregon and Colorado in preparing to roll out a tightly regulated medical psilocybin program by late 2027. Proponents of psilocybin, the naturally occurring psychoactive ingredient in “magic mushrooms,” celebrated in April when Democratic Gov. Michelle Lujan Grisham signed the legislation allowing the program into law.
Some studies on psilocybin-aided treatment have been promising, they point out, and there is a new wave of interest in popular culture.
The practice of microdosing, or using very small amounts of a psychedelic for treatment, has hit the mainstream. News outlets recently reported Dr. Casey Means, President Donald Trump’s pick for surgeon general, suggested in a newsletter her use of magic mushrooms helped her find a romantic partner.
New Mexico’s Senate Bill 219, known as the Medical Psilocybin Act, establishes a regulated program for the medical use of psilocybin to treat qualified medical conditions such as major treatment-resistant depression, PTSD, substance use disorder and end-of-life care. It soared through both the House and Senate with wide bipartisan support.
The program, set to be fully launched by Dec. 31, 2027, calls for psilocybin to be administered to patients by a New Mexico-licensed health care provider in an approved clinical setting.
Advertisement
State Rep. Angel Charley, D-Acoma, outside the San José de la Laguna Mission Church in Laguna Pueblo in May 2023. Charley noted in her speech about the bill on the Senate floor that psychedelic healing is no novel concept for Indigenous communities in the Southwest. “This medicine is not groundbreaking,” she said. “It is only new to Western modalities of healing.”
Advertisement
Michael Benanav/Searchlight New Mexico
Psychedelic healing is no novel concept for Indigenous communities in the Southwest, state Sen. Angel Charley, D-Acoma, noted earlier this year when she addressed colleagues about the bill on the Senate floor.
“This medicine is not groundbreaking,” she said. “It is only new to Western modalities of healing.”
Charley recognized legendary Oaxacan curandera María Sabina during her floor speech.
Advertisement
“And so I ask those voting today that we carry this knowledge forward,” she said. “This is something that our communities have offered people for hundreds of years.”
Guardrails for safe delivery
Oregon and Colorado established their medical psilocybin programs by way of ballot initiatives, so New Mexico became the first state in the U.S. to approve a program through legislation. According to the online network Psychedelic Alpha, legislation related to “psychedelic medicines” has been introduced in at least 15 states.
Still illegal under federal law, however, psilocybin is listed as a Schedule 1 drug — defined as a substance “with no currently accepted medical use and a high potential for abuse.”
Advocates and lawmakers have pointed to the stiff guardrails New Mexico’s program would have to prevent abuse of the substance.
Sen. Craig Brandt, R- Rio Rancho, one of the sponsors of SB 19, said, “I think we put the guardrails in there the right way to where it’s not like the medical marijuana program. It’s a very limited application. So, there’s very few things that it can be used for.”
Advertisement
Sen. Craig Brandt, R-Rio Rancho, speaks on the Senate floor in February 2024. Brandt was one of the sponsors of Senate Bill 19, which was approved with wide bipartisan support.
New Mexican file photo
Advertisement
He noted patients could only receive psilocybin treatment in an approved clinical setting, without an option of taking the substance home.
Psilocybin research has shown benefits for those struggling with PTSD, Brandt said, adding lawmakers heard testimony from veterans in committee hearings.
“I do think New Mexico has a chance to do this somewhat differently, with more integrity. I would put it that way,” said Janine Sagert, a retired psychologist in Santa Fe who has advocated for psilocybin since the 1970s. “I’m very hopeful about that.”
Those who have advocated for New Mexico’s medical psilocybin program are quick to point out treatments have nothing to do with hallucinating or getting high, and magic mushrooms are not legal for recreational use in the state.
Advertisement
Adele Getty — director of the nonprofit organizing The Enchanted State, a September conference on the psychedelic movement at the Lensic Performing Arts Center, believes this is a good idea.
“Oregon did a massive [decriminalization]. That was not beneficial for Oregon; Portland in particular,” Getty said. “I think Colorado is doing a better job in terms of implementation. And Oregon has actually learned and, I would say, upgraded its whole system.”
Despite the popularity of SB 19, a handful of state lawmakers opposed the program.
“My opposition to [SB] 219 is strictly due to the very little we know about this drug,” Rep. Luis Terrazas, R-Santa Clara, wrote in a text message. “While I am always supportive of therapies to help alleviate symptoms of depression and PTSD, I was not comfortable with the information provided in the debate to support it.”
Still, Terrazas hopes the therapy will be safe for those who use it and that it “truly provides relief where traditional drugs have failed.”
Advertisement
“Working with psilocybin has really allowed me to sit with my grief,” Crystal Romero said. “Depression doesn’t have to consume your life. I was able to reconnect with myself, reconnect with kids, reconnect with my community.”
Gabriela Campos/The New Mexican
Advertisement
How the program will take shape
SB 19 calls for the establishment of the Medical Psilocybin Advisory Board, with nine members “knowledgeable about the medical use of psilocybin,” including at least one who is enrolled in a tribal nation, one veteran and one behavioral health advocate.
Applications will open soon for this panel, which will be tasked with recommending patient qualifications and assisting the state Department of Health in developing, monitoring and evaluating best practices for producers and clinicians.
Aspects of the program will take shape over the next two years with input from stakeholders, said Dominick Zurlo, director of the Health Department’s Center for Medical Cannabis; the agency’s title will soon be expanded to include the word “psilocybin.”
“That’s what these next two years are about, about making sure that we are setting up the best requirements for those providers in the clinics,” Zurlo said.
Advertisement
Brandt noted patients will spend a substantial amount of time with a clinician while treatment is administered. For proponents like Romero, this is an important aspect of the program.
Before her first experience with the treatment in Jamaica, Romero worked with a coach to prepare. There also were people at her side to coach her through the treatment, she said.
Crystal Romero holds a small glass mushroom made for her by her friend after New Mexico’s Senate Bill 219, known as the Medical Psilocybin Act, was signed into law this year. The program, set to be fully launched by Dec. 31, 2027, calls for psilocybin to be administered to patients by a New Mexico-licensed health care provider in an approved clinical setting.
Advertisement
Gabriela Campos/The New Mexican
The Health Department is now developing the process for implementing the program, including treatment protocols, safety guidelines, clinician and producer training requirements and data-collection methods to evaluate the program’s effectiveness.
State funding will be funneled toward the nascent program, starting with $1 million in fiscal year 2026 to add new employees to the Health Department, Zurlo said.
Advertisement
The psilocybin law calls for a new Medical Psilocybin Treatment Fund to aid qualified low-income patients and a Medical Psilocybin Research Fund to support studies by universities and health care providers.
The University of New Mexico’s Health Sciences Center launched new psilocybin-related research last summer, including a study on RE104 — a novel compound related to psilocybin — for postpartum depression.
The Health Department will be responsible for overseeing producers in New Mexico, as psilocybin administered by clinicians must be cultivated and produced within the state.
“We need to ensure it is actually grown and produced [here] so we are not putting anybody at risk on a federal level with crossing state lines,” Zurlo said.
A Legislative Finance Committee analysis found an estimated 1,748 New Mexicans might use the program each year, based on numbers of patients in Oregon, a state with a 5-year-old medical psilocybin program.
Advertisement
“That’s going to depend a lot on how many clinics we end up permitting,” Zurlo said. “We’re really going to be evaluating that over the next two years to help determine how many can be served within those first several years.”
It is difficult to predict how many providers will become certified to participate, he said. Oregon, with a population about twice as large as New Mexico’s, had around 32 clinics permitted in its program’s first year, he noted.
Romero, who was raised around the state in Taos, Las Vegas and Mora, is optimistic about the program. “It’s really going to bring some healing in the state,” she said. “If we can rebuild ourselves, we can rebuild our communities.”
In the nearly two months since New Mexico head coach Eric Olen and staff have been in charge, they’ve rebuilt the Lobos roster by adding 13 names to next season’s team.
With the summer recruiting circuit getting underway, Olen and staff have begun looking at their next targets in the high school class beginning with 2026 names. A rising senior now on New Mexico’s radar is forward Trevon Carter-Givens. Playing for Team WhyNot in front of college coaches during the May viewing period, Carter-Givens averaged eight points and seven rebounds per game while helping his team to a 3-0 record.
Following the weekend, his recruitment continued to expand with offers from Creighton, TCU and New Mexico coming in. This followed offers from Florida State, Seton Hall, UNLV and San Francisco in April.
Carter-Givens played his first two high school seasons at Templeton High School in California’s Central Coast, a school with less than 800 enrolled. He made the move to Southern California Academy prior to his junior season, pairing up with a team that is primarily made up of top recruits. He’s settled into his role as a big man and continues to show off his improvements over the past year.
Advertisement
Eric Olen’s initial roster at New Mexico is heavy with players plucked from the transfer portal, as has become a normal procedure across the country, even more so in the case of a new head coach left with virtually nothing on the roster. The Lobos have signed three high school recruits for 2025, Uriah Tenette, Jake Hall and Sir Marius Jones. Tenette and Hall were previously signed with play for Olen at UC San Diego while Jones was headed for UC Irvine but is following assistant coach Michael Wilder to Albuquerque.
Eight of New Mexico’s commitments over the past two months have come from the transfer portal with Chris Howell and Milos Vincentic, starting the run of commitments while following Olen and staff over from UC San Diego. New Mexico’s other two commitments have come from different paths. Forward Antonio Chol averaged 20 points and eight rebounds per game this past season at Garden City Community College after starting his career at Rutgers. New Mexico’s newest commitment, Tomislav Buljan, comes to the college game after several professional seasons in Europe. The 6-foot-8, 22-year-old Buljan is a native of Croatia and has four seasons of eligibility.
